EirGenix, Inc.’s Post

This March, I'm speaking at Central European BioForum. Those who follow our Viseven journey probably know that in 2019, we took a great focus on global expansion. Ever since came riveting times of new challenges, lessons, failures, and successes. During the panel discussion "How to enter the US market?" I'll gladly share how Viseven managed the intricacies of this global expansion and cooperation with bio-related companies. #CEBioForum2024 is said to be the place where you meet key players in biotech in CEE in one spot in order to find business development opportunities. Together with Nataliya Kulyba, Maciej Najdzion, Oleksandra Yashyna (Zikh), and Dominika Sosnowska, we're looking forward to this opportunity. Meanwhile, let's connect! #martech #biotech #globalbusiness

🌱 Growth Mindset: The Heart of Innovation at Bioz 🌱 At Bioz, we thrive on the principle of a growth mindset. Every challenge is a chance to learn, innovate, and advance scientific research with our Bioz Badges. Embrace growth, embrace possibilities. Let's innovate together! #Bioz #GrowthMindset #BiozInnovation

🚀 Exclusive Interview with Jeremy Elser, CEO of Ship of Theseus 🌱 (EWMA Innovation Competition Winner 2024) Excited to share our conversation with Jeremy Elser, founder and CEO of Ship of Theseus, a pioneering biotechnology company. Jeremy recently won the EWMA Innovation Competition, and in this interview, he shares insights into his journey, their groundbreaking work in wound care, and the future of Ship of Theseus. Key takeaways from the interview: 🌍 Ship of Theseus' mission: Leveraging cutting-edge biotechnology to improve wound healing through transcription factor-based treatments. 🏆 Impact of winning the EWMA Innovation Award: Boosting the company's recognition and opening doors to new partnerships and collaborations. 🔬 Exciting pipeline: Their lead product, Trireme, is set to enter clinical trials by 2025. Don’t miss this insightful conversation! 🎥 https://lnkd.in/d8-PBi82 #biotechnology #innovation #woundcare #ShipOfTheseus #biotech #EWMAInnovationCompetition #healthtech #clinicaltrials #EWMAInnovationAlliance

The development and commercialization of disruptive therapeutic products derived from marine biodiversity could help bring more attention to the importance of the ocean's health. Recognizing the ocean as a source of valuable medical compounds can lead to increased efforts to protect and preserve marine ecosystems. As the demand for marine-derived therapeutic products grows, it's crucial to ensure that these resources are harvested sustainably and that marine biodiversity is protected. #biomarine2024 #nanoparticles

Pharma & Medtech climate performance Industry benchmark from Green Innovation Group released today! We're excited to share the industry benchmark for global pharma and medtech companies climate performance according to SBTi data. In Pharma decarbonisation commitment is now standard the next frontier is climate action, MedTech is playing catch-up…

🌱 Spring into Action this Equinox with Scale Biosciences! Just like the natural world, we're gearing up for growth and renewal! With new products sprouting, collaborations blossoming, and events in full bloom, this season promises to be one of innovation and discovery. Let's cultivate success together! #SingleCellSpring #singlecell #vernalequinox What cellular innovations are you hoping to discover this spring?

Join our Syneos Health Consulting team at JPM's Biotech Showcase next week in this panel discussion to learn more about how to invest for success in today's challenging environment!

EuropaBio - the European Association for Bioindustries congratulates Ursula von der Leyen on her re-election for a second mandate as President of the European Commission for the period 2024-2029. We welcome President von der Leyen's continued leadership and her commitment to advancing competitiveness, innovation, and resilience, whilst fostering the biotech revolution to modernise our economies within the European Union. Dr Claire Skentelbery, Director General of EuropaBio commented “Biotechnology is rightfully recognised by President von der Leyen as central to Europe’s future. As a critical technology where the EU already has significant scientific and economic strength, we look forward to strong progress and delivery towards the EU ambitions of competitiveness and resilience”. EuropaBio reinforces President von der Leyen’s commitment to presenting an EU Biotech Act in 2025, supporting the Clean Industrial Deal. Read our full statement at: https://lnkd.in/eGcq37wF

Hold onto your lab coats, we just launched our new Bio-Tech R&D page on our website! 🥼✨ Join us on a journey through the realms of innovation, where data-driven discoveries and biotech brilliance collide. Check it out: https://lnkd.in/dbrerGJz #BioInnovators #BioTechBreakthroughs #RnDInnovation #DataRevolution #InnovateWithData #TechInBiotech #InnovationStation #Scieline #ScielineWebsite

How do CEOs of CDMOs navigate uncertainty and drive growth? Find out during the 2nd Annual Bioprocessing Venture, Innovation & Partnering Conference on August 21, 2024, in Boston, MA, part of CHI's Bioprocessing Summit. Hear from this all-star panel featuring industry leaders as they share their experiences, perspectives, and foresight on steering their organizations through dynamic and complex business landscapes to achieve sustainable growth and industry leadership. Ran Zheng (CEO, Landmark Bio) Steve Favaloro (President & CEO, Genezen) Patrick Lucy (President & CEO, RoslinCT) Rahul Singhvi (Co-Founder & CEO, Resilience) Gain insights into strategies for navigating market volatility, balancing short-term pressures with long-term goals, overcoming regulatory challenges, leveraging technology for innovation, and fostering resilience within organizations. Don’t miss this opportunity to connect with key players driving the future of bioprocessing. For more details, visit https://lnkd.in/gzryU8G2 #bioprocessing #innovation #biotech #conference #partnerships #CDMO #CEO